Clinical Trial Update: Biomarkers of LONG COVID (LONG COVID_LCM)

View source ↗

Summary

A clinical trial investigating biomarkers in Post-acute sequelae of SARS-CoV-2 infection (Long COVID) has completed; no specific results are described in the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: IRCCS Policlinico S. Donato | Conditions: Long COVID | Status: COMPLETED